Dennis QUAID and Kimberly Quaid, Parents and Next Friends of Zoe Grace Quaid and Thomas Boone Quaid, Plaintiffs-Appellants,
v.
BAXTER HEALTHCARE CORPORATION, Defendant-Appellee.
Appellate Court of Illinois, First District, Third Division.
*1238 Harry C. Lee, Keith L. Davidson, Laura P. Gordon, Law Offices of Harry C. Lee, Susan E. Loggans, Susan E. Loggans & Associates, P.C., Chicago, IL, for Plaintiffs-Appellants.
Michele Odorizzi, Sheila M. Finnegan, Sara E. Rauh, Mayer Brown LLP, Chicago, IL, for Defendant-Appellee.
Presiding Justice MURPHY delivered the opinion of the court:
Plaintiffs, Dennis and Kimberly Quaid, parents and next friends of Zoe Grace and Thomas Boone Quaid, brought an action in the circuit court of Cook County against defendant, Baxter Healthcare Corp., alleging negligence and strict liability. The trial court granted defendant's motion to dismiss pursuant to the doctrine of forum non conveniens, finding that California is a substantially more appropriate forum. On appeal, plaintiffs argue that the trial court abused its discretion in granting thе motion.
I. BACKGROUND
In November 2007, newborn twins Zoe and Thomas Quaid were hospitalized for treatment of a staph infection at Cedars-Sinai Hospital[1] in Los Angeles, California. On November 18, 2007, their physician prescribed 10 unit/ml of Hep-lock to keep their intravenous lines clear, but hospital personnel made a "medical error" and administered 10,000 unit/ml of Heparin instead.
On December 4, 2007, plaintiffs filed a two-count complaint against Baxter alleging strict liability and negligence. Plaintiffs alleged that the 10 unit/ml vials of Hep-lock and 10,000 unit/ml vials of Heparin manufactured by defendant were in an *1239 unreasonably dangerous condition because the labels of both vials had a blue background, which made them difficult to distinguish. They alleged that the background colors should have been different and that the vials should have been completely distinguishable in size and shape. They further alleged that defendant was negligent because it (1) failed to recall or repackage the 10,000 units/ml vial of Heparin, or issue an urgent warning to healthcare providers, when it had actual knowledge of infant deaths that occurred as a result of medication errors, (2) sold different dosages with the same blue background, (3) failed to issue an urgent warning about the fatal medication errors to all healthcare providers who purchased the product or require that such providers initiate mandatory education and implement safety measures so that a fatal medication error would not occur, and (4) failed to provide an adequate after-market solution to the existing vials and to assure that none of the existing vials were used until the after-market solution was implеmented.
Defendant filed a motion to dismiss the complaint pursuant to the doctrine of forum non conveniens. It argued that plaintiffs reside in California, the incident occurred in California, all nonparty fact witnesses are likely to be residents of California, and California law would apply. Defendant alleged that it has a "large presence" in California, with 2,600 employees working there, and all of the witnesses who could testify as to how and why the medication error occurred live in California, beyond the subpoena power of the court. Furthermore, defendant alleged that if the case were to proceed in Illinois, it would be unable to implead Cedars-Sinai because the hospital does not do business in Illinois and has no apparent contacts with the state.
Defendant submitted statistical records showing that in 2006, the average time between the opening of a case and a jury verdict in Cook County was 38.1 months. In 2005 through 2006 in Los Angeles County, 65% of general unlimited civil cases were disposed of in less than 12 months, 86% in less than 18 months, and 94% in less than 24 months.
Defendant also relied on the California Department of Health Services' investigation of the error and conclusion that there were "multiple failures by the facility to adhere to established policies & procedures for safe medication use": pharmacy technicians mistakenly sent the pediatric unit 100 vials of 10,000 unit/ml of Heparin instead of the 10 ml/unit vials of Hep-Lock used for flushing intravenous lines, and the nurses who administered the vials then violated hospital procedures by failing to read the labels. The Department of Health Services ordered the hospital to take immediate correсtive action to remedy the deficiencies in its procedures and training, which the Department concluded placed patients in "immediate jeopardy" of serious injury or death.
In February 2007, after a similar medication error at Methodist Hospital in Indianapolis, Indiana, involving 10 unit/ml vials of Hep-lock and 10,000 unit/ml vials of Heparin, defendant distributed a Food-and-Drug-Administration (FDA)-approved "Important Medication Safety Alert" warning that a medication error had occurred when two Heparin products were confused and advising healthcare providers to take certain steps to guard against further errors.
The parties were permitted to take discovery limited to the forum non conveniens issue. In their response to the motion, plaintiffs alleged that defendant is incorporated in Delaware, with its corporate headquarters in Deerfield, Illinois, *1240 and its registered agent in Chicago. Defendant operates in three business segments, with the subject Heparin products falling under the Medication Delivery Segment, which has offices in Deerfield and Round Lake, Illinois. The plant where the vials were processed and labeled is in Cherry Hills, New Jersey, and some of the employees with responsibility over these products work at a Baxter facility in New Providence, New Jersey. Baxter's distribution center for the vials is in Memphis, Tennessee.
Baxter had 42 employees involved in consideration of labeling and packaging changes for the Heparin and Hep-Lock products: 33 current employees, who work in the Illinois and New Jersey facilities, and 9 former employees whose last known addresses are in New Jersey, Pennsylvania, Illinois, and South Carolina. It also identified 37 members of its safe packaging committee, inсluding 31 current employees, who work at Baxter's Illinois and New Jersey facilities, and 6 former employees, who live in Illinois, New Jersey, and Pennsylvania. In addition, the Baxter employees involved in completing its new drug applications and adverse events reports for the Heparin and Hep-Lock products work at facilities in New Jersey and Illinois.
The last known addresses of the people significantly involved in pharmacovigilance and adverse events related to the subject Heparin products before March 2006 are in Pennsylvania and Park Ridge, Illinois. The Baxter employees involved in pharmacovigilance who investigated the September 2006 incident at Methodist Hospital and the November 2007 incident regarding plaintiffs' children currently work at Baxter's Deerfield facility, and the last known addresses of the two former employees who may have sought information about the incident at Methodist Hospital are in Pennsylvania and Texas. The Baxter employees who had interaction with the FDA concerning the incidents at Methodist Hospital and Cedars-Sinai currently work at Baxter's Illinois and New Jersey facilities. Current Baxter employees involved in the drafting, distribution, or review of the medication safety alert work at Baxter's Illinois and New Jersey facilities, and various former employees involved in that work live in New Jersey (three), Illinois (one), and Pennsylvania (one).
According to a Baxter news release, defendant introduced a "New Drug Safety Initiative" in 2007 for the purpose of reducing "medication errors by creating enhanced packaging that provides additional safeguards to assist clinicians in the correct idеntification of critical medications." In October 2007, Heparin was the first medication offered with new enhanced labeling. Defendant did not issue a recall of the Heparin lacking the new labeling. Defendant's current employees involved in its "New Drug Safety Initiative" work at its facilities in Illinois and New Jersey, and its former employees involved in that work have last known addresses in Pennsylvania and Minnesota.
As part of the "New Drug Safety Initiative," Baxter conducted interviews with more than 100 pharmacists, physicians, and nurses to identify areas for improvement. The companies that Baxter retained to interview clinicians conducted those interviews in Pennsylvania, Florida, New Jersey, Florida, Texas, and Ohio. The Baxter employee who authorized the research works at the New Providence, New Jersey, facility.
Records rеlating to the Heparin and Hep-Lock products are located in Illinois and New Jersey. Furthermore, defendant has sold its Heparin products to various hospitals in Illinois and has marketed Heparin products in clinical journals that are *1241 delivered to residents and clinicians in Illinois.
The trial court noted that California would not be inconvenient to either party, as plaintiffs live there and defendant has 2,600 employees there. Furthermore, citing Berbig v. Sears Roebuck & Co., Inc.,
In addition, the trial court noted that although there were many witnesses located in different states, "the majority of them are employees of defendant that can be compelled to testify in any forum." Court congestion is greater in Cook County than Los Angeles County, and California residents have a greater interest in this case than Cook County residents: "only California residents are concerned with the quality of medical care rendered in California hospitals." Finally, "defendant makes a convincing argument that the substantive law of California will apply to this case." Accordingly, the court granted defendant's motion to dismiss.
Plaintiffs filed a petition for leave to appeal with this court pursuant to Supreme Court Rule 306(a)(2) (210 Ill.2d R. 306(a)(2)). On October 30, 2008, we granted the petition.
II. ANALYSIS
A. Jurisdiction
First, defendant argues that we lack jurisdiction because plaintiffs filed a petition for leave to appeal pursuant to Rule 306(a)(2) instead of a notice of appeal pursuant to Rule 301 (155 Ill.2d R. 301) ("Every final judgment of a circuit court in a civil case is appealable as of right. The appeal is initiated by filing a notice of appeal. No other step is jurisdictional."). According to defendant, a dismissal under the doctrine of forum non conveniens is a final judgment that cаn only be appealed under Rule 301. Thus, defendant argues, plaintiffs' failure to file a notice of appeal from the dismissal order deprives this court of jurisdiction.
In interpreting a supreme court rule, this court must follow the same guidelines as for statutory interpretation. Giannini v. Kumho Tire U.S.A., Inc.,
We reject defendant's argument. First, the plain language of Rule 306(a)(2) permits a party to file a petition for leave to appeal from an order granting a motion *1242 to dismiss on the grounds of forum non conveniens:
"(a) Orders Appealable by Petition. A party may petition for leave to appeal to the Appellate Court from the following orders of the trial court:
* * *
(2) from an order of the circuit court allowing or denying a motion to dismiss on the grounds of forum non conveniens, or from an order of the circuit court allowing or denying a motion to transfer the case to another county within this State on such grounds." 210 Ill.2d R. 306(a)(2).
Since Rule 306 specifically permits a party to "petition for leave to appeal to the Appellate Court * * * from an order of the circuit court allowing or denying a motion to dismiss on the grounds of forum non conveniens" (210 Ill.2d R. 306(a)(2)), we find that plaintiffs' compliance with that rule did not deprive this court of jurisdiction.
Second, Supreme Court Rule 187 (134 Ill.2d R. 187), under which defendant brought its motion to dismiss pursuant to the doctrine of forum non conveniens, belies defendant's assertion that the order was final. Rule 187(c)(2) provides as follows:
"Dismissal of an action under the doctrine of forum non conveniens shall be upon the following conditions:
(i) if the plaintiff elects to file in another forum within six months of the dismissal order, the defendant shall accept servicе of process from that court; and
(ii) if the statute of limitations has run in the other forum, the defendant shall waive that defense.
If the defendant refuses to abide by these conditions, the cause shall be reinstated for further proceedings in the court in which the dismissal was granted. If the court in the other forum refuses to accept jurisdiction, the plaintiff may, within 30 days of the final order refusing jurisdiction, reinstate the action in the court in which the dismissal was granted. The costs attending a dismissal may be awarded in the discretion of the court." 210 Ill.2d R. 187(c)(2).
Where dismissal is subject to "conditions" and the case will be reinstated if a defendant fails to comply with those conditions, the dismissal order was not final.
Defendant also argues that a dismissal on forum non conveniens grounds "has always been considered" the entry of a final judgment, which is appealable as of right. However, Rule 306 was amended December 17, 1993, effective February 1, 1994, from "denying a motion to dismiss on the grounds of forum non conveniens" (134 Ill.2d R. 306) to "allowing or denying a motion to dismiss on the grounds of forum non conveniens" (210 Ill.2d R. 306). (Emphasis added.) Furthermore, the three Illinois cases that defendant cites were decided before the 1994 amendment to Rule 306. See Certain Underwriters at Lloyd's London v. Bertrand Goldberg Associates, Inc.,
Defendant further claims that Rule 306 applies only to nonfinal orders that grant or deny a motion to dismiss on forum non conveniens groundsfor example, a defendant can seek leave to appeal if its motion is denied, and a plaintiff can seek leave to appeal if some, but not all, defendants are dismissed on forum non conveniens grounds. To interpret the rule otherwise, *1243 defendant argues, would be contrary to article VI, section 6 of the Illinois Constitution (Ill. Const. 1970, art. VI, § 6). According to defendant, the supreme court has the power under the constitution to provide for discretionary interlocutory appeals, but "it has no power to adopt rules that would convert a litigant's absolute right to appeal a final judgment into a discretionary appeal." Rule 306, however, does not contain the limits as to the number of parties or claims that defendant seeks to impose. Furthermore, with the plain language of Rule 306, our supreme court has determined that filing a petition for leave to appeal is the proper procedure for seeking review of a forum non conveniens dismissal.
Our research did not reveal any cases specifically addressing this issue. In Whirlpool Corp. v. Certain Underwriters at Lloyd's London,
The plain language of Rule 306(a)(2) provides that a party may petition for leave to appeal to the appellate court from an order of the trial court allowing or denying a motion to dismiss on the grounds of forum non conveniens. Therefore, we conclude that plaintiffs' failure to file a notice of appeal did not deprive this court of jurisdiction.
B. Forum Non Conveniens
Under section 2-101 of the Code of Civil Procedure, an action must generally be commenced in the county of residence of any dеfendant who is joined in good faith or in the county where the cause of action arose. 735 ILCS 5/2-101 (West 2004). If more than one potential forum exists, the equitable doctrine of forum non conveniens may be invoked to determine the most appropriate forum based on fairness and convenience. Griffith v. Mitsubishi Aircraft International, Inc.,
*1244 In resolving forum non conveniens questions, the trial court must balance private interest factors, which affect the convenience of the parties, and public interest factors, which affect the administration of the court. Woodward v. Bridgestone/Firestone, Inc.,
Private interest factors include (1) the convenience of the parties; (2) the relative ease of access to sources of testimonial, documentary, and real evidence; and (3) all other practical problems that make trial of a case easy, expeditious, and inexpensive, for example, the availability of compulsory process to secure attendance of unwilling witnesses, the cost to obtain attendance of unwilling witnesses, and the ability to view the premises, if appropriate. Guerine,
The public interest factors include (1) the intеrest in deciding localized controversies locally; (2) the unfairness of imposing the expense of a trial and the burden of jury duty on residents of a county with little connection to the litigation; and (3) the administrative difficulties presented by adding further litigation to court dockets in already-congested fora. Guerine,
A trial court does not weigh the private factors against the public factors; rather, it must evaluate the total circumstances of the case in deciding whether the defendant has proven that the balance of factors strongly favors transfer. Guerine,
As a preliminary matter, although a plaintiff has a substantial interest in choosing the forum where his rights will be vindicated, "the plaintiff's interest in choosing the forum receives somewhat less deference when neither the plaintiff's residence nor the site of the accident or injury is located in the chosen forum." Guerine,
Defendant argues that where nonresident plaintiffs bring a tort action in a state far from the site of the incident in question, it is logical to assume that they have chosen the forum not because it is convenient, but because they are seeking to obtain some advantage from the selection of the forum. "`[W]hen the plaintiff is foreign to the forum chosen and the action *1245 that gives rise to the litigation did not occur in the chosen forum * * *' `it is reasonable to conclude that the plaintiff engaged in forum shopping to suit his individual interests, a strategy contrary to the purposes behind the venue rules.'" Dawdy,
The first private interest factor is the convenience of the parties. Because "[w]e live in a smaller world" and "are connected by interstate highways, bustling airways, telecommunications, and the world wide web," "[t]oday, conveniencethe touchstone of the forum non conveniens doctrinehas a different meaning." Guerine,
Plaintiffs argue that Illinois would be more convenient for the numerous former and current Baxter employees that defendant identified in its responses to plaintiffs' interrogatories, many of whom live in Illinois. The following current employees work at defendant's Illinois and New Jersey facilities: those who interacted with the FDA concerning the incidents at Methodist Hospital and Cedars-Sinai; those involved in the drafting, distribution, or review оf the medication safety alert; 37 members of the safe packaging committee; 33 employees involved in consideration of labeling and packaging changes for the Heparin and Hep-Lock products; employees involved in completing its new drug applications and adverse events reports for the Heparin and Hep-Lock products; and employees involved in defendant's "New Drug Safety Initiative." The people significantly involved in pharmacovigilance and adverse events related to the subject Heparin products before March 2006 live in Pennsylvania and Park Ridge, Illinois, and the Baxter employees involved in pharmacovigilance who investigated the incident at Methodist Hospital and the incident regarding plaintiffs' children currently work at Baxter's Deerfield facility. Fоrmer employees whose testimony plaintiffs claim would be relevant live in New Jersey, Illinois, Pennsylvania, South Carolina, Minnesota, and Texas. Furthermore, the companies that Baxter retained to interview clinicians as part of the "New Drug Safety Initiative" conducted those interviews in Pennsylvania, Florida, New Jersey, Florida, Texas, and Ohio. The Baxter employee who authorized the research works at Baxter's New Providence, New Jersey, facility.
Therefore, the majority of defendant's relevant current employees seem to live in Illinois and New Jersey, and the remaining witnesses are scattered among several states. It is well settled that when potential witnesses are scattered among different forums, none enjoys a predominant connection to the litigation. Dawdy,
Defendant responds that it will be nеcessary for Cedars-Sinai employees to testify regarding the medication error and for the California Department of Health Service *1246 employees to testify about its investigation. Furthermore, all postoccurrence medical treatment occurred in California. If the case were tried in Illinois, defendant argues, plaintiffs would be able to compel the appearance of defendant's employees, but defendant would not be able to compel the appearance of the Cedars-Sinai and California Department of Health Service employees.
In Gridley v. State Farm Mutual Automobile Insurance Co.,
Similarly, in Woodward, 29 potential witnesses, including occurrence witnesses and medical personnel, were located in Australia. The court noted that if the case remained in Illinois, witnesses in Australia were not compelled to come to the United States, and if the forum was changed to Australia, American witnesses would not be compelled to appear in Australia. Woodward,
Finally, in Jones v. Searle Laboratories,
The court found that there was no compulsory process to secure the attendance of unwilling witnesses from the United Kingdom, and the cost of transporting willing witnesses to Illinois was substantial. Jones,
Similarly, Illinois lacks subpoena power over Cedars-Sinai and California Department оf Health Service employees, witnesses that reside in California. If the litigation occurred in California, defendant would have access to those witnesses, and "it is unlikely that [plaintiffs] would have the same difficulty securing the attendance" of defendant's employees, most of whom reside in Illinois. Gridley,
Plaintiffs argue that if the case were tried in California, they would be unable to subpoena former Baxter employees or contractors. Defendant responds that the testimony of the former employees is largely irrelevant and cumulative of that of Baxter's current employees. Furthermore, one of the former employees, an attorney involved in the drafting, distribution, or review of the February 2007 safety alert, stated in an affidavit that she was willing to appear voluntarily at trial in California. In Ellis v. AAR Parts Trading, Inc.,
Plaintiffs emphasize that this is a products liability case against Baxter, not a negligence action against Cedars-Sinai. They contend that the testimony of the California-based witnesses could have no bearing on their products liability case, and there is no dispute over what happened at Cedars-Sinai. Defendant responds that the hospital's knowledge of the warnings issued in the wake of the medication error in Indianapolis and the actions it took in response to those warnings are relevant to the issue of proximate cause, as well as the application of the "learned intermediary" doctrine. We note that, as the manufacturer of a prescription drug, defendant's warnings ran to the health professionals who prescribed the medication, not to the patients who received them. See Kennedy v. Medtronic, Inc.,
Plaintiffs further argue that, to the extent that it would be necessary for California-based witnesses to testify regarding the "admitted and already documented events in California," such testimony could be taken via deposition and presented as testimony at trial. See 188 Ill.2d R. 206; 210 Ill.2d R. 212. As the supreme court *1248 noted in Jones, however, "[a]lthough defendant could depose these witnesses, depositions have been deemed an inadequate substitute for live testimony." Jones,
In a similar vein, if the case remains in Illinois, defendant would not be able to file a third-party complaint against Cedars-Sinai, since there is no basis for Illinois to assert long-arm jurisdiction over the hospital. Therefore, if the case proceeded in Illinois, defendant would have to litigate against plaintiffs here and against the hospital in California. In Cook v. General Electric Co.,
Unlike GE, defendant has not yet filed a third-party complaint against Cedars-Sinai. Plaintiffs cite Woodward, which involved a car accident in Australia that was allegedly caused by a defective roof in the Ford Explorer and a defective Firestone tire. The court held that it would have been premature for the trial court to remove the case on the basis that a third-party cause of action may be filed whеre the defendants had not filed such an action and the record contained no indication that they plan to do so. Woodward,
While defendant has not yet filed a third-party complaint against Cedars-Sinai, it apparently contemplates such a filing, since it raised this issue in its motion to dismiss pursuant to the doctrine of forum non conveniens. In addition, in Woodward, the potential third-party defendants' liability was far from clear: they were simply witnesses who arrived on the scene shortly after the accident, and one оf them struck the plaintiff's vehicle, which was still in the roadway. Here, it could be argued that plaintiffs' complaint establishes at least some liability on the part of Cedars-Sinai, as it alleges that the 10 unit/ml Hep-Lock was prescribed for the *1249 infants but "a medical error was made by personnel of Cedars-Sinai Hospital and 10,000 unit/ml of Heparin was administered instead."
We find Woodward to be further distinguishable because the decision to use the product in that case was made by the plaintiff instead of a third party. We agree with the trial court that there is an "important distinction" between this case and other product liability cases because here, "the decision to use a product that is mislabeled or contains inadequate warnings was made by a highly trained third party not subject to the court's jurisdiction."
Plaintiffs next maintain that records pertaining to the Heparin and Hep-Lock products are located in Illinois and New Jersey, not California. However, "the location of documentary evidence has become less significant because today's technology allows documents to be copied and transported easily and inexpensively." Ammerman v. Raymond Corp.,
It seems unlikely that the jury would need to view the premises. Although it is the possibility, rather than the necessity, of a jury view that is important, "the importance of this factor diminishes due to the fact that this case primarily concerns a products liability claim." Dawdy,
Finally, plaintiffs argue that the location of the parties' attorneysin Chicagofavors retention of the case in Illinois. While a court may consider this factor, "little weight should be accorded it." Boner v. Peabody Coal Co.,
With respect to the first public interest factor, which сoncerns having local interests resolved locally, plaintiffs argue that the trial court erred in concluding that California residents have a far greater interest in this case than do Illinois residents. Where a case involves questions of product liability, the concern of having local interests resolved locally "is of less significance because products liability cases have broader implications." Ammerman,
"Indeed, Cook County certainly has an interest in resolving a controversy concerning the sale of an allegedly defective product by companies conducting business in its forum. Moreover, we note that Caterpillar, the other corporate defendant, has a registered agent in Cook County, and thus, Cook County has an interest in deciding a controversy involving one of its residents." Ammerman,379 Ill.App.3d at 892 ,318 Ill.Dec. 950 ,884 N.E.2d 1221 , citing Langenhorst, *1250219 Ill.2d at 451 ,302 Ill.Dec. 363 ,848 N.E.2d 927 .
It also follows that jurors residing in Illinois have an interest in hearing and resolving such a claim. Ammerman,
Nevertheless, defendant correctly observes that California's "paramount interest" in this matter is demonstrated by the swift action it took after the incident to investigate and discipline the hospital. By contrast, there is no evidence that the State of Illinois took any action against defendant. As the trial court noted, while "all residents are interested in the safe labeling of drugs disрensed in their counties, only California residents are concerned about the quality of medical care rendered in California hospitals."
Furthermore, while Illinois residents have a strong interest in the operations of businesses located there, merely conducting business within a county in Illinois does not affect the forum non conveniens analysis. Gridley,
"If the fact that the defendant conducts business * * * in the plaintiff's chosen forum were dispositive, the forum non conveniens `doctrine itself would be entirely vitiated, and no transfer would ever be obtained. Rather, plaintiff's choice would be elevated to the stature of a dispositive consideration, which is patently not to be allowed.'" Dawdy,207 Ill.2d at 182 ,278 Ill.Dec. 92 ,797 N.E.2d 687 , quoting Franklin v. FMC Corp.,150 Ill.App.3d 343 , 347,103 Ill. Dec. 570 ,501 N.E.2d 887 (1986).
The trial court also noted that defendant "makes a convincing argument that the substantive law of California will apply to this case." Plaintiffs argue that "it is not clear" whether Illinois or California law applies where the corporate decisions were likely made in Illinois and there is no real dispute as to the medication error.
A choice-of-law determination is required only when a difference in the law will make a difference in the outcome. Townsend v. Sears, Roebuck & Co.,
*1251 Townsend held that "a strong presumption exists that the law of the place of injury * * * governs the substantive issues herein," unless plaintiffs can demonstrate that "Illinois has a more significant relationship to the occurrence and the parties with respect to a particular issue." (Emphasis in original.) Townsend,
First, the injury occurred in California. Townsend cautioned that "situations exist where the place of the injury will not be an important contact, for example, where the place of the injury was fortuitous." Townsend,
The second and third factors appear to be a "wash." Townsend,
After applying the Townsend factors, we find that California law will probably apply in this case. While plaintiffs argue that the need to apply another state's law is not dispositive to the forum non conveniens analysis, Gridley held that the need to apply another state's law is a "significant factor favoring dismissal of a suit on grounds of forum non conveniens." Gridley,
Finally, the "court congestion factor, by itself, is relatively insignificant." Dawdy,
We find that plaintiffs' choice of forum is entitled to less deference because Illinois is neither their residence nor the site of the accident or injury. Furthermore, the lack of compulsory process to secure unwilling witnesses, defendant's inability to file a third-party complaint for contribution against Cedars-Sinai in Illinois, California's strong interest in regulating medication errors in its own hospitals, and the possible application of California law support the trial court's determination.
*1252 III. CONCLUSION
This court has jurisdiction under Rule 306(a)(2) to decide this appeal. We further find that the trial court did not abuse its discretion in granting the motion to dismiss pursuant to the doctrine of forum non conveniens.
Affirmed.
THEIS and QUINN, JJ., concur.
NOTES
Notes
[1] Plaintiffs did not file suit against Cedars-Sinai; however, they have settled their individual claims and claims on behalf of their children against the hospital.
